PTJ
DPLO

Paul Tudor Jones’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Paul Tudor Jones’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,829
Closed -$175K – 1329
2017
Q2 		$175K Sell
11,829
-10,432
-47% -$174K 0.01% 913
2017
Q1 		$355K Sell
22,261
-12,639
-36% -$182K 0.01% 898
2016
Q4 		$440K Buy
34,900
+24,700
+242% +$460K 0.01% 787
2016
Q3 		$286K Buy
+10,200
New +$342K 0.01% 1052
2016
Q1 		– Sell
-16,499
Closed -$565K – 2060
2015
Q4 		$565K Sell
16,499
-7,501
-31% -$234K 0.02% 780
2015
Q3 		$690K Buy
+24,000
New +$1.03M 0.02% 572
2015
Q2 		– Sell
-16,750
Closed -$579K – 1748
2015
Q1 		$579K Buy
+16,750
New +$456K 0.02% 659

Other funds holding DPLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's DPLO Position: Q3 2017 in Review

Paul Tudor Jones sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 11,829 shares — an estimated $175K sold.

Paul Tudor Jones first reported a position in DPLO in Q1 2015 and held it in 7 quarters. The position peaked at $690K in Q3 2015. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Paul Tudor Jones reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 11,829 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $175K.
  • Paul Tudor Jones first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 7 quarters.
  • Paul Tudor Jones's DIPLOMAT PHARMACY, INC. position peaked at $690K in Q3 2015.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Tudor Investment Corp's 13F filing for Q3 2017, filed 14 Nov 2017.